Beneficial effects of thiamine on recognition memory and P300 in abstinent cocaine-dependent patients

Psychiatry Research

Volumn 70, Issue 3, 1997, Pages 165-174

  Easton, Caroline J ^a   Bauer, Lance O ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cocaine; Event related potentials; Memory; P300; Thiamine

Indexed keywords

PLACEBO; THIAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RECOGNITION; STIMULUS RESPONSE; TASK PERFORMANCE;

ADULT; ATTENTION; CEREBRAL CORTEX; COCAINE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MENTAL RECALL; PARIETAL LOBE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; THIAMINE;

EID: 0030854969     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00024-3     Document Type: Article

References (59)

1. Antal, A., Istvan, K., Bodis-Wollner, I., 1994. Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey. Physiol. Behav. 56, 161-166.
2. Bajalan, A.A., Wright, C.E., van der Vliet, V.J., 1986. Changes in human visual evoked potentials caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 49, 175-182.
3. Bartel, P., Blom, M., Robinson, E., van der Meyden, C., Sommers, D.K., Becker, P., 1990. Effects of two anticholinergic drugs on electroretinograms and visual evoked potentials in healthy human subjects. Neuropsychobiology 24, 205-209.
4. Bauer, L.O., 1987. Effects of information processing demands on physiological response patterns. Hum. Factors 29, 213-234.
5. Bauer, L.O., 1993a. Electroencephalographic evidence for residual CNS hyperexcitability during cocaine abstinence. Am. J. Addict. 2, 287-298.
6. Bauer, L.O., 1993b. Eye movements in recovering substance abusers: a prospective study. Addict. Behav. 18, 465-472.
7. Bauer, L.O., 1994. Photic driving of EEG alpha activity in recovering cocaine-dependent and alcohol dependent patients. Am. J. Addict. 3, 49-57.
8. Bauer, L.O., 1996. Psychomotor and electroencephalographic sequelae of cocaine dependence. In: Majewska, M.D. (Ed.), Neuropathology and Neurotoxicity of Cocaine/Stimulant Abuse. NIDA Res Monogr 163. U.S. Government Printing Office, Washington, D.C., pp. 66-93.
9. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., 1961. An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561-571.
10. Berry, J., van Gorp, W.G., Herzberg, D.S., Hinkin, C., Boone, K., Steinman, L., Wilkins, J.N., 1993. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 32, 231-237.
11. Blass, J.P., Gleason, P., Brush, D., 1988. Thiamine and Alzheimer's disease. Arch. Neurol. 45, 833-835.
12. Bowden, S.C., Ambrose, M.L., Whelan, G., 1995. Thiamine enhances memory performance in alcohol dependent patients without WKS. Presented at the International Neuropsychological Society Twenty-Third Annual Meeting, Seattle, Washington, 8-11 February.
13. Bucholz, K.K., Cadoret, R., Cloninger, C.R., Dinwiddie, S.H., Hesselbrock, V.M., Nurnberger, J.I., Reich, T., Schmidt, I., Schuckit, M.A., 1994. A new semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA J. Stud. Alcohol 55, 149-158.
14. Butterworth, R.F., 1993. Pathophysiology of cerebellar dysfunction in the Wernicke-Korsakoff syndrome. Can. J. Neurol. Sci. 20, S12-36.
15. Callaway, E., Halliday, R., Naylor, H., Schechter, G., 1985. Effects of oral scopolamine on human stimulus evaluation. Psychopharmacology 85, 133-138.
16. Chiappa, K.H., 1990. Evoked Potentials in Clinical Medicine. Raven Press, New York.
17. Coles, M.G.H., Donchin, E., Porges, S.W., 1986. Psychophysiology: Systems, Processes, and Applications. Guilford Press, New York.
18. Consolo, S., Girotti, P., Russi, G., Di Chiara, G., 1992. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J. Neurochem. 59, 1555-1557.
19. Eder, L., Hirt, L., Dunant, Y., 1976. Possible involvement of thiamine in acetylcholine release. Nature 264, 186-188.
20. Eder, L., Dunant, Y., Loctin, F., 1980. Thiamine and cholinergic transmission in the electric organ of Torpedo II. Effects of exogenous thiamine and analogues on acetylcholine release. J. Neurochem. 35, 1287-1296.
21. Faust, D., Fogel, B.S., 1989. The development and initial validation of a sensitive bedside cognitive screening test. J. Nerv. Ment. Dis. 177, 25-31.
22. Fogel, B. 1991. The high sensitivity cognitive screen. Int Psychogeriatr, November.
23. Gehlert, D.R., Morey, W.A., Wamsley, J.K., 1985. Alterations in muscarinic cholinergic receptor densities induced by thiamine deficiency: autoradiographic detection of changes in high- and low-affinity agonist binding. J. Neurosci. Res. 13, 443-452.
24. 3H]-acetylcholine release by cocaine. J. Pharmacol. Exp. Ther. 2632, 757-761.
25. Gold, M.S., Washton, A.M., Dackis, C.A., 1985. Cocaine abuse: neurochemistry, phenomenology, and treatment. NIDA Res. Monogr. Ser. 61, 130-150.
26. Imperato, A., Obinu, M.C., Gessa, G.L., 1993. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur. J. Pharmacol. 2382 (3), 377-381.
27. Imperato, A., Obinu, M.C., Demontis, M.V., Gessa, G.L., 1992. Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. Eur. J. Pharmacol. 229, 265-267.
28. Jonas, J.M., Gold, M.S., 1986. Cocaine abuse and eating disorders. Lancet 1, 390-391.
29. Jones, R., 1985. The pharmacology of cocaine. NIDA Res. Monogr. Ser. 50, 34-53.
30. Langlais, P.J., Mair, R.G., Anderson, C.D., McEntee, W.J., 1988. Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats. Neurochem. Res. 1312, 1199-1206.
31. Lee, R.S., Strahlendorf, H.K., Strahlendorf, J.C., 1985. Enhanced sensitivity of cerebellar Purkinje cells to ion-tophoretically-applied serotonin in thiamine deficiency. Brain Res. 3271 (2), 249-258.
32. Mair, R.G., Anderson, C.D., Langlais, P.J., McEntee, W.J., 1985. Thiamine deficiency depletes cortical norepinephrine and impairs learning processes in the rat. Brain Res. 360, 273-284.
33. Meador, K., Loring, D., Nichols, M., Zamrini, E., Rivner, M., Posas, H., Thompson, E., Moore, E., 1993. Preliminary findings of high dose thiamine in dementia of Alzheimer's type. J. Geriatr. Psychiatry Neurol. 64, 222-229.
34. Meador, K.J., Nichols, M.E., Franke, P., 1993. Evidence for a central cholinergic effect of high-dose thiamine. Ann. Neurol. 34, 724-726.
35. Melamed, J.I., Bleiberg, J., 1986. Neuropsychological deficits in freebase cocaine abusers after cessation of use. Presented at the 93rd Annual Convention of the American Psychological Association, 23 August, Washington, D.C.
36. Misra, A.L., Vadlamani, N.L., 1976. Molecular complexes of cocaine, its active metabolites and some other stimulants with thiamine. Res. Commun. Chem. Pathol. Pharmacol. 152, 401-404.
37. O'Malley, S., Adamse, M., Heaton, R.K., Gawin, F.H., 1992. Neuropsychological impairment in chronic cocaine abusers. Am. J. Drug Alcohol Abuse 18, 131-144.
38. O'Malley, S.S., Gawin, F.H., 1990. Abstinence symptomatology and neuropsychological impairment in chronic cocaine abusers. In: Spencer, J.W., Boren, J.J. (Eds.), Residual Effects of Abused Drugs on Behavior. NIDA Res Monogr 101. U.S. Government Printing Office, Washington, D.C., pp. 179-191.
39. O'Malley, S.S., Gawin, F.H., Heaton, R.K., Kleber, H.D., 1989. Cognitive deficits associtated with cocaine abuse. Presented at the Annual Meeting of the American Psychiatric Association, San Francisco, California, May 1989.
40. Pfefferbaum, A., 1995. Event related potentials in the study of psychiatric disorders. Arch. Gen. Psychiatry 52, 559-563.
41. Rao, V.L., Butterworth, R.F., 1995. Thiamine phosphatases in human brain: regional alterations in patients with alcoholic cirrhosis. Alcohol. Clin. Exp. Res. 192, 523-526.
42. Ray, P.G., Meador, K.J., Loring, D.W., Murro, A.M., Buccafusco, J.J., Yang, X.H., Zamrini, E.Y., Thompson, W.O., 1991. Effects of scopolamine on visual evoked potentials in aging and dementia. Electrorencephalogr. Clin. Neurophysiol. 805, 347-351.
43. Ricceri, L., Tirassa, P., Aloe, L., Alleva, E., 1993. Postnatal cocaine exposure affects neonatal passive avoidance performance and cholinergic development in rats. Pharmacol. Biochem. Behav. 452, 283-289.
44. Roberts, L.A., Bauer, L.O., 1993. Reaction time during cocaine versus alcohol withdrawal: longitudinal measures of visual and auditory suppression. Psychiatry Res. 46, 229-237.
45. Rusted, J.M., 1988. Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berlin) 96, 487-492.
46. Schmeller, T., Sporer, F., Sauerwein, M., Wink, M., 1995. Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptors. Pharmazie. 507, 493-495.
47. Schwartz, R.H., Bogema, S., Thorne, M.M., 1990. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine speciments. Pediatr. Emerg. Care 6, 147-149.
48. Selzer, M.L., 1971. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am. J. Psychiatry 127, 1653-1658.
49. Semlitsch, H.V., Anderer, P., Schuster, P., Presslich, O., 1986. A solution for reliable and valid reduction of ocular artifacts applied to the P300 ERP. Psychophysiology 23, 695-703.
50. Sloan, E.P., Fenton, G.W., Standage, K.P., 1992. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory. Biol. Psychiatry 316, 600-606.
51. Spitz, H., Rosecan, J., 1987. Cocaine Abuse: New Directions in Treatment and Research. Brunner/Mazel, Chicago, pp. 72-73.
52. Sternberg, S., 1975. Memory scanning: new findings and current controversies. Q. J. Exp. Psychol. 27, 132.
53. Trouillas, P., 1993. The cerebellar serotoninergic system and its possible involvement in cerebellar ataxia. Can. J. Neurol. Sci. 203, S78-82.
54. Victor, M., Adams, R.D., Collines, G.H., 1989. The Wernicke-Korsakoff syndrome and Related Neurological Disorders Associated With Alcohol Use and Malnutrition. F.A. Davis, Philadelphia.
55. Volkow, N.D., Mullani, N., Gould, K.L., Adler, S., Drajewski, K., 1988. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br. J. Psychiatry 152, 641-648.
56. Waldenlind, L., 1978. Studies on thiamine and neuromuscular transmission. Acta. Physiol. Scand. 459, 135.
57. Yamashita, H., Zhang, Y.X., Nakamura, S., 1993. The effects of thiamine and phosphate esters on dopamine release in the rat striatum. Neurosci. Lett. 1582, 229-231.
58. Zeigler, S., Lipton, J., Toga, A., Ellison, G., 1991. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res. 5521, 27-35.
59. Zocchi, A., Pert, A., 1994. Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output. Psychopharmacology 1153, 297-304.